Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: David Nierengarten Head of Health Care Equity Research Wedbush Securities Discussing investing in biotech stocks, inlcuding Blueprint Medicines.

2356 232

Suggested Podcasts

BBC Radio 4

Chicago Tribune's Louisa Chu and WBEZ's Monica Eng

Matt Gondek - Deconstructive Pop Artist

Callie Ammons

Federal Reserve Bank of San Francisco